Yield10 Bioscience, Inc. (YTEN)
- Previous Close
0.2570 - Open
0.2460 - Bid 0.2219 x 100
- Ask 0.2388 x 100
- Day's Range
0.2131 - 0.2600 - 52 Week Range
0.1800 - 3.2900 - Volume
1,094,560 - Avg. Volume
5,134,350 - Market Cap (intraday)
3.612M - Beta (5Y Monthly) 1.61
- PE Ratio (TTM)
-- - EPS (TTM)
-1.8200 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.50
Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focuses on commercializing products using the Camelina oilseeds. Its products include Camelina oil for use as a low-carbon feedstock oil for biofuels; Omega-3 oils for human nutrition; and PHA bioplastics. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
www.yield10bio.com29
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: YTEN
Performance Overview: YTEN
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: YTEN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: YTEN
Valuation Measures
Market Cap
3.61M
Enterprise Value
5.75M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
31.06
Price/Book (mrq)
--
Enterprise Value/Revenue
95.81
Enterprise Value/EBITDA
-0.41
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-150.28%
Return on Equity (ttm)
-1,508.09%
Revenue (ttm)
60k
Net Income Avi to Common (ttm)
-14.46M
Diluted EPS (ttm)
-1.8200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.07M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-4.57M